AstraZeneca To Acquire Alexion In $39 Billion Deal To Push Into Immunology
AstraZeneca has decided to buy Alexion in a deal of $39 billion, valuing Alexion at $175 per share on Saturday.…
AstraZeneca has decided to buy Alexion in a deal of $39 billion, valuing Alexion at $175 per share on Saturday.…
This is CNBC's live blog covering all the latest news on the coronavirus outbreak. All times below are in Eastern…
This is CNBC's live blog covering all the latest news on the coronavirus outbreak. All times below are in Eastern…
[The stream is slated to start at 11:30 a.m. ET. Please refresh the page if you do not see a…
This is CNBC's live blog covering all the latest news on the coronavirus outbreak. All times below are in Eastern…
This is CNBC's live blog covering all the latest news on the coronavirus outbreak. All times below are in Eastern…
This is CNBC's live blog covering all the latest news on the coronavirus outbreak. All times below are in Eastern…
This is CNBC's 24-hour blog covering all the latest news on the coronavirus outbreak. All times below are in Eastern…
This is CNBC's 24-hour blog covering all the latest news on the coronavirus outbreak. All times below are in Eastern…
This is CNBC's live blog covering all the latest news on the coronavirus outbreak. All times below are in Eastern…